Searchable abstracts of presentations at key conferences in endocrinology

ea0021p211 | Endocrine tumours and neoplasia | SFEBES2009

Investigating the role of HIF-1α in tumour growth and metastasis in an in vivo model of thyroid cancer

Burrows Natalie , Resch Julia , Mejin Melissa , Brabant Georg , Williams Kaye

Intratumoural hypoxia is associated with aggressive and metastatic phenotypes with poor prognosis. The transcription factor HIF-1α is a key regulator of hypoxia-mediated gene expression that is documented to promote tumour growth and metastasis in a wide range of cancers. However its role in the development of thyroid carcinomas is relatively unknown. We have previously shown that HIF-1α is highly active in a range of thyroid cancer cell lines with highest activity o...

ea0020p34 | Adrenal | ECE2009

The utility of the low dose dexamethasone suppression test in patients diagnosed with an adrenal incidentaloma

Debono Miguel , Durrington Charlotte , Williams Scott , Newell-Price John

Objective: The diagnosis of subclinical Cushing’s syndrome in patients with incidentalomas is not always straight forward and a number of different criteria have been used. The 1 mg overnight dexamethasone suppression test has been recommended as a screening test, followed up by other tests of the hypothalomo–pituitary–adrenal axis to confirm the diagnosis. In this study we investigate whether the low-dose dexamethasone suppression test offers additional informa...

ea0019p388 | Thyroid | SFEBES2009

HIF-1α and β-catenin functionally interact in the regulation of carbonic anhydrase-IX (CA-IX), an important marker of tumour hypoxia

Burrows Natalie , Resch Julia , Williams Kaye , Brabant Georg

Background: Intratumoural hypoxia is associated with an aggressive and metastatic phenotype and poor prognosis. The transcription factor Hypoxia-inducible Factor-1α (HIF-1α) is a key regulator of hypoxia, inducing the expression of genes which promote tumour cell survival, such as carbonic-anhydrase IX (CA-IX) playing a role in cell adhesion, pH regulation and dedifferentiation of the tumours. Here we investigated whether there is cross talk between the HIF-1 and Wnt...

ea0015p145 | Diabetes, metabolism and cardiovascular | SFEBES2008

Tamm-Horsfall glycoprotein mutants, which cause familial juvenile hyperuricaemic nephropathy are retained in the endoplasmic reticulum, resulting in delayed maturation and trafficking to the plasma membrane

Williams Sian , Reed Anita , Antignac Corinne , Galvanovskis Juris , Thakker Rajesh

Background: Mutations in the UMOD gene, which encodes the Tamm-Horsfall Glycoprotein (THP), cause FJHN, an autosomal dominant disorder characterised by gout and renal failure. THP is a 640 amino acid glycosylphosphatidylinositol-anchored protein, containing three Epidermal Growth Factor (EGF)-like domains, a cysteine-rich region and a Zona Pelllucida (ZP) domain. THP is translated into the Endoplasmic Reticulum (ER) lumen, glycosylated in the Golgi apparatus, trafficked...

ea0013p331 | Thyroid | SFEBES2007

Hypoxia inducible factor (HIF-1α) in thyroid carcinoma cell lines

Cowen Rachel , Williams Kaye , West Catherine , Resch Julia , Brabant Georg

Background: Tissue hypoxia is a hallmark of rapidly proliferating tumours which most frequently adapt and prosper under low oxygen tension. The transcription factor, HIF-1α, is mediating these effects and induces target genes involved in survival, invasion and resistance to drugs and radiation. No data are available on the functional regulation of HIF-1α in thyroid carcinoma cells.Methods: Using thyroid carcinoma cells derived from papillary (N...

ea0011p50 | Clinical case reports | ECE2006

Recurrent congenital neonatal hyperthyroidism in a mother with Graves’ disease (post radio-ablation) on thyroxine replacement

Kumar J , Rajendran P , Lapworth R , Buchanan C , Williams C

Thyroid dysfunction is not uncommon in pregnancy and is associated with various maternal, foetal and neonatal complications. We report the occurrence of neonatal hyperthyroidism in two successive pregnancies in a post radio-ablation mother with Graves’ disease who is on thyroxine replacement.Mother: A 30-year-old lady, treated for Graves’ thyrotoxicosis with radioiodine 10 years ago, was on thyroxine 100 mcg replacement for hypothyroidism. She ...

ea0011p891 | Thyroid | ECE2006

Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone (T3): identification of a thyroid hormone response element (TRE) in the murine Fgfr1 promoter

O’Shea PJ , Williams GR , Cheng SY

T3 is essential for skeletal development and T3-actions in bone are mediated mainly by the nuclear receptor TRα1. We previously identified that FGFR1 is a T3-responsive gene in osteoblasts by subtraction hybridization. In mice that harbor a dominant negative mutation PV, FGFR1 mRNA expression is reduced in TRα1PV mutants that exhibit skeletal hypothyroidism and increased in TRβPV/PV mice with skeletal thyrotoxicosis. In this study, primary ...

ea0009oc17 | Oral Communication 2: Reproduction and growth | BES2005

Disruption of intramembranous and endochondral bone development in TRalpha 2 null mice

Bassett J , O'Shea P , Nordstrom K , Vennstrom B , Williams G

T3 is essential for skeletal development and its actions are mediated by two nuclear receptors (TRs), with TR alpha (TRa) being functionally predominant in bone. The TRa1 isoform binds T3 with high affinity and activates target gene expression in response to hormone. TRa2, however, does not bind T3 or regulate transcription in response to hormone. Intriguingly, TRa2 is expressed at high levels from early in development in all tissues and is conserved in all mammals, although i...

ea0008oc15 | Neuroendocrinology and Reproduction | SFE2004

PGF2alpha -FP receptor signalling is a potential regulator of endometrial vascular function

Sales KJ , Williams ARW , Anderson RA , Naor Z , Jabbour HN

Prostaglandin F2a (PGF) receptor (FP) expression is up-regulated in neoplastic epithelial and perivascular cells in endometrial adenocarcinomas, indicating potential regulation of vascular function by PGF via the FP receptor. This study investigated the potential role of PGF-FP receptor signalling in modulating vascular function in endometrial adenocarcinomas.Endometrial biopsies were obtained in accordance with Ethics Committee guidance with ...

ea0007p290 | Clinical case reports | BES2004

Spontaneously resolving hypopituitarism followed by primary adrenal lymphoma-related phenomena?

Abdalla T , Adams C , Wenham S , Williams G , Wayte A , Wilton A

A 67 year old man with 1 month history of malaise was referred when his thyroid profile suggested secondary hypothyroidism with a fT4 of 4.9 picomoles per litre, fT3 3.4 picomoles per litre and TSH 0.03 milli units per litre. Physical signs were unremarkable. Investigations:- cortisol (random) 294 nanomols per litre, prolactin 960 micro units per millilitre, testosterone < 0.04 nanomols per litre, FSH 5.2 units per litre, LH 0.07 units per litre and IGF-1 17.7 nanomols per ...